Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudotumor cerebri

J E Ahlskog, B P O'Neill

    Annals of Internal Medicine
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Pseudotumor cerebri, a condition of increased intracranial pressure, can lead to vision loss. Steroid therapy is recommended for persistent symptoms, with shunting considered for severe cases.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    40-Year Incidence of Early-Onset Parkinson's Disease in Southeast Minnesota.

    Journal of Parkinson's disease·2023
    Same author

    The clinical spectrum and natural history of pure akinesia with gait freezing.

    Journal of neurology·2016
    Same author

    Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.

    Parkinsonism & related disorders·2016
    Same author

    Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy.

    Parkinsonism & related disorders·2016
    Same author

    Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms.

    Parkinsonism & related disorders·2015
    Same author

    Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease.

    CNS drugs·2015
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Neurology
    • Ophthalmology

    Background:

    • Pseudotumor cerebri involves elevated cerebrospinal fluid pressure.
    • Symptoms mimic general intracranial pressure elevation.
    • Endocrine studies in patients are typically normal.

    Purpose of the Study:

    • To summarize the understanding of pseudotumor cerebri.
    • To outline recommended treatment strategies.

    Main Methods:

    • Review of existing literature on pseudotumor cerebri.
    • Analysis of treatment outcomes from uncontrolled studies.

    Main Results:

    • Vision loss is a significant risk, affecting 4-12% of patients.
    • The exact cause of pseudotumor cerebri remains unknown.
  • Spontaneous remission rates limit the interpretation of treatment studies.

    • Conclusions:

    • A short course of steroid therapy is suggested for symptomatic cases unresponsive to initial observation and lumbar punctures.
    • Surgical shunting is reserved for refractory cases or imminent vision loss.